Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model.

Nature communications·2026
Same author

Many Ways Out: Beyond the Two-State Model of Protein Unfolding.

ACS omega·2026
Same author

Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 Inhibitors.

Journal of medicinal chemistry·2026
Same author

Ribonucleic acid as an active driver of protein aggregation in neurodegeneration.

Current opinion in structural biology·2026
Same author

Giredestrant immobilizes the estrogen receptor to exert potent antitumor efficacy against ER-active breast cancers.

Cell chemical biology·2026
Same author

Hsp70 diversification and repurposing across the tree of life: Lessons from the evolutionary and mechanistic trajectory of the Hsp70-Hsp110 chaperone system.

The FEBS journal·2026

Related Experiment Video

Updated: May 22, 2026

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
06:49

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans

Published on: December 17, 2021

Explaining the length threshold of polyglutamine aggregation.

Paolo De Los Rios1, Marc Hafner, Annalisa Pastore

  • 1Laboratory of Statistical Biophysics, ITP SB EPFL, Lausanne, Switzerland. paolo.delosrios@epfl.ch

Journal of Physics. Condensed Matter : an Institute of Physics Journal
|May 19, 2012
PubMed
Summary

A minimum length of 35 residues is required for polyglutamine repeats to aggregate and cause neurodegenerative diseases like Huntington's. This length threshold is explained by polymer physics modulating protein association and dissociation rates.

More Related Videos

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Related Experiment Videos

Last Updated: May 22, 2026

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
06:49

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans

Published on: December 17, 2021

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Area of Science:

  • Molecular Biology
  • Biophysics
  • Neuroscience

Background:

  • Polyglutamine (PolyQ) repeats are implicated in neurodegenerative diseases.
  • A length threshold of ~35 residues is critical for PolyQ aggregation and pathology.
  • The molecular basis for this length threshold remains poorly understood.

Purpose of the Study:

  • To investigate the biophysical mechanisms underlying the polyglutamine length threshold.
  • To explore the role of polymer and statistical physics in PolyQ aggregation.
  • To provide a new framework for understanding PolyQ-mediated neurodegeneration.

Main Methods:

  • Review of fundamental polymer and statistical physics principles.
  • Analysis of how repeat length influences association and dissociation rates of PolyQ polypeptides.
  • Theoretical modeling of PolyQ aggregation dynamics.

Main Results:

  • The existence of a length threshold is consistent with length-dependent modulation of association and dissociation rates.
  • Differing functional dependencies of these rates on length rationalize the threshold.
  • This provides a biophysical explanation beyond the search for a specific aggregation-triggering structure.

Conclusions:

  • The polyglutamine length threshold is a consequence of fundamental polymer physics, not a unique aggregation-prone structure.
  • Length-dependent kinetics of polypeptide association/dissociation explain aggregation propensity.
  • Understanding these dynamics may reveal cellular mechanisms preventing PolyQ aggregation and disease onset.